1501 Bull Lea Road
Formed to manufacture and exclusively sell the Réjuve injectable medical device to treat Degenerative Disc Disease (DDD), low back pain, and related spinal diseases such as scoliosis.
A significant opportunity exists to better serve both surgical and non-surgical patients by offering an injectable solution that directly strengthens disc tissues, improves disc nutritional flow, reduces neural compression caused by disc bulge, and corrects the cause of the
instability associated with spinal disc diseases without the cost and risk of surgery.
Founder: Stephen Hochschuler
CEO: Lyle Hawkins
CSO: Tom Hedman